Although previous studies have demonstrated expression of ErbB2 in a subset of patients with B-lineage-ALL and CML in B-lymphoid blast crisis, they have not established whether ErbB2 protein expression or activity was associated with negative prognostic indicators [3], [4]. Here, ERBB2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.